Last reviewed · How we verify

NCT05564260

The Effects of Virtual Reality and Kaleidoscope

Completed NA Last updated 3 October 2022
What this trial tests

NA trial testing Kaleidescope in Fear in 156 participants. Completed in 1 December 2020.

Timeline
1 January 2020
Primary endpoint
1 July 2020
1 December 2020

Quick facts

Lead sponsorOndokuz Mayıs University
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingdouble
Primary purposesupportive care
Enrollment156
Start date1 January 2020
Primary completion1 July 2020
Estimated completion1 December 2020
Sites1 location across Turkey (Türkiye)

Drugs / interventions tested

Conditions studied

Sponsor

Ondokuz Mayıs University

Who can join

Adults 7 to 12, any sex, with Fear or Pain. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

In literature review, many studies have been found to support the positive effects of various nonpharmacological methods in the alleviation of pain and fear created by invasive procedures.This study was carried out to determine the effects of kaleidoscope and cartoon watching using the virtual reality glasses on the pain and fear states of children during blood draw procedure.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Fear

Currently open trials in the same condition.

Other Ondokuz Mayıs University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05564260.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing